← Scoopfeeds — Intelligent news, curated.
AbbVie bets $10.9 billion on Apogee in next-generation immunology growth push
business

AbbVie bets $10.9 billion on Apogee in next-generation immunology growth push

Investing.com · Jun 22, 2026, 11:31 AM · Also reported by 4 other sources

AbbVie bets $10.9 billion on Apogee in next-generation immunology growth push

Read full story on Investing.com → More top stories

Also covered by

Bloomberg Markets AbbVie to Buy Apogee Therapeutics for $10.9 Billion Yahoo Finance Why AbbVie Is Spending $11 Billion to Buy Apogee Therapeutics Yahoo Finance AbbVie acquires Apogee Therapeutics for $10.9 billion Yahoo Finance AbbVie to acquire Apogee Therapeutics in $10.9B deal

More in business

Yahoo Finance
Tech stocks live: Tech stocks mixed ahead of Micron earnings Wednesday
Investing.com
Outdoor Holding earnings beat, revenue topped estimates
MarketWatch
U.S. oil prices fall below $74 a barrel on 60-day pause on Iranian oil sanctions
Investing.com
OnespaWorld stock hits all-time high at 28.15 USD
Investing.com
Metlen Energy & Metals issues shares for incentive plan
Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop